Form 4: DarioHealth Corp. Chief Commercial Officer Acquires 5,000 Shares

DarioHealth Corp.'s Chief Commercial Officer, Steven Charles Nelson, purchased 5,000 shares of common stock at a price of $0.9092 per share.

Summary

• Steven Charles Nelson, the Chief Commercial Officer of DarioHealth Corp., acquired 5,000 shares of the company's common stock on November 12, 2024.
• The purchase price was $0.9092 per share.
• Following this transaction, Mr. Nelson directly owns 55,000 shares of DarioHealth Corp. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but this is a relatively small transaction and does not provide a strong indication of future performance.

Positives

• The purchase of shares by a company officer can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders who trade their company's stock. It provides transparency into the transactions of company officers.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical for company officers and directors who buy or sell shares in their own company.
• The filing is consistent with regulatory requirements for insider trading.

Stakeholder Impact

• The purchase of shares by a company officer may be viewed positively by shareholders.

Key Dates

Keywords

DarioHealth Corp, insider trading, stock purchase, Steven Charles Nelson, Chief Commercial Officer, common stock, share acquisition